Julie G.
- Country
- France
- Department
- Hematology
Research Overview
- Phase 2 Study of Mezigdomide, Carfilzomib, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
- Phase 2 Study of Belantamab Mafodotin and Mezigdomide in Patients with Relapsed/Refractory Multiple Myeloma Following BCMA-Targeting CAR-T or Bispecific Antibody Therapy
- Phase 2 Study of Cemsidomide Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 142 of 270 partner sites.
Specializations
Hematologic Malignancies
Clinical research activity is strongly centered on acute leukemia, myelodysplastic syndromes, and lymphoid cancers, with involvement across newly diagnosed, relapsed, and high-risk disease settings.
- Acute myeloid leukemia
- Acute lymphoblastic leukemia
- Diffuse large B-cell lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
Interest also extends to chronic lymphocytic leukemia, mantle cell lymphoma, peripheral T-cell lymphoma, Waldenström macroglobulinemia, and primary plasma cell leukemia.
Solid Tumor Oncology
The investigator is involved in a broad portfolio of solid tumor studies, especially in tumors with an advanced, metastatic, or biomarker-selected profile.
- Breast cancer
- Non-small cell lung cancer
- Pancreatic cancer
- Colorectal cancer
- Ovarian cancer
Additional areas include prostate cancer, renal cell carcinoma, hepatocellular carcinoma, endometrial cancer, melanoma, and gastroesophageal cancers.
Immune-Mediated and Inflammatory Diseases
Research activity also covers autoimmune and chronic inflammatory diseases, reflecting interest in long-term disease control and symptom management beyond oncology.
- Crohn's disease
- Ulcerative colitis
- Rheumatoid arthritis
- Multiple sclerosis
- IgA nephropathy
Other therapeutic domains include severe asthma, idiopathic pulmonary fibrosis, and Raynaud phenomenon.
Cardiovascular and Thromboembolic Medicine
The clinical portfolio includes studies in cardiovascular disease, stroke prevention, and thrombosis-related care, with attention to patients at elevated vascular risk.
- Atrial fibrillation
- Ischemic stroke
- Myocardial infarction
- Atherosclerosis
- Cardiac failure
Related interests include venous thromboembolism, coronary syndromes, out-of-hospital cardiac arrest, and primary prevention of atherosclerotic cardiovascular disease.
Supportive and Translational Therapeutic Areas
Additional trial involvement spans supportive oncology and biomarker-driven treatment selection, with a focus on treatment optimization in complex patient populations.
- Transfusion-dependent anemia
- Metastatic disease control
- Biomarker-selected cancer treatment
- Maintenance therapy
- Treatment de-escalation
These interests are reflected across post-treatment surveillance, recurrence prevention, and precision oncology settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.